HIGHFDA DRUG

Teva Metoprolol Succinate 25 mg Recall for 18,780 Bottles Nationwide in 2026

Teva Pharmaceuticals is recalling 18,780 bottles of Metoprolol Succinate Extended-Release Tablets, 25 mg, distributed nationwide. The recall is due to failed dissolution specifications that could affect dosing. Patients should stop using affected bottles and contact Teva or their healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 29, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 29, 2026
Hazard Level
HIGH
Brand
Metoprolol Succinate
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Metoprolol Succinate
Product type
Metoprolol Succinate Extended-Release Tablets 25 mg
Model numbers
0715J251, 0716J251, 0717J251, 0715J252, 0716J252, 0717J252
UPC codes
45963-676, 45963-709, 45963-677, 45963-678, 45963-709-11, 45963-709-96, 45963-676-11, 45963-676-96 +3 more
Sizes
100-tablet bottle, 1000-tablet bottle
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 29, 2026

  2. Reported by FDA DRUG

    March 11, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter

About This Product

Metoprolol succinate extended-release tablets are a generic beta-blocker used to treat high blood pressure, chest pain, and certain heart conditions. They are available in 25 mg extended-release tablets in 100-tablet and 1000-tablet bottles.

Why This Is Dangerous

Dissolution specification failure means the tablet may not release the drug consistently, potentially leading to underdosing and reduced treatment effectiveness.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients relying on consistent dosing may experience unmanaged blood pressure or heart rate. There are no reported injuries or deaths in this recall.

Practical Guidance

How to identify if yours is affected

  1. Check NDCs 45963-709-11 and 45963-709-96 on your bottle

Where to find product info

Bottle label shows NDC and lot number; official recall page listed in article.

What timeline to expect

4-6 weeks for recall processing is typical; actual processing times vary by manufacturer and pharmacy.

If the manufacturer is unresponsive

  • Document all contact attempts with Teva and your healthcare provider
  • File a complaint with the FDA if the company is unresponsive
  • Consult your pharmacist for guidance on alternatives

How to prevent similar issues

  • Regularly check recalls for prescription medications on FDA and manufacturer sites
  • Always verify NDC and lot numbers when receiving medications
  • Discuss any recalls with your healthcare provider before continuing treatment

Documentation advice

Keep the recall notice, bottle labels showing NDC and lot numbers, and all correspondence with Teva or your provider.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Metoprolol Succinate Extended-Release Tablets, 25 mg. NDCs: 45963-709-11 (100-tablet bottles) and 45963-709-96 (1000-tablet bottles). Quantity recalled: 18,780 bottles. Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ 07054. Sold nationwide as Rx-only.

Key Facts

  • 18,780 bottles recalled nationwide
  • Remedy: Stop use and contact Teva or your healthcare provider

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product TypeMetoprolol Succinate Extended-Release Tablets 25 mg
Sold At
Multiple Retailers

Product Details

Model Numbers
0715J251
0716J251
0717J251
0715J252
0716J252
+1 more
UPC Codes
45963-676
45963-709
45963-677
+8 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

LACTATED RINGERS
Presence of
Read more